Radiation Oncology/Therapy: Page 319

IsoRay taps VP
By AuntMinnie.com staff writers
Medical isotope developer IsoRay has appointed Anthony Pasqualone as vice president of business development in charge of sales.
November 23, 2008
Proton therapy reduces bone marrow toxicity compared with IMRT
By Edward Susman
Tighter control of how much radiation is focused on a tumor and how much affects adjacent structures appears to result in less bone marrow toxicity among patients treated with proton beam therapy, when compared with conventional intensity-modulated radiation therapy (IMRT).
November 23, 2008
Nucletron receives FDA clearance for RT viewer
By AuntMinnie.com staff writers
Radiation oncology firm Nucletron has received clearance from the U.S. Food and Drug Administration for its radiotherapy (RT) viewer.
November 20, 2008
FDA clears Aktina radiotherapy system
By AuntMinnie.com staff writers
Radiation oncology system developer Aktina has received clearance from the U.S. Food and Drug Administration for a new radiation therapy system.
November 20, 2008
Accuray gets delisting notice
By AuntMinnie.com staff writers
Radiotherapy firm Accuray has received a delisting notification from the Nasdaq stock market.
November 19, 2008
Bracco inks deal with Marillion
By AuntMinnie.com staff writers
Italian contrast firm Bracco Imaging and oncology pharmaceutical developer Marillion Pharmaceuticals have signed a license agreement.
November 19, 2008
TomoTherapy investor urges sale of firm
By AuntMinnie.com staff writers
A California investment firm that owns 4% of radiation therapy firm TomoTherapy is urging the Madison, WI, company to sell itself as a means of "boosting shareholder value."
November 19, 2008
Single-session breast radiotherapy safe for pregnant women, study finds
By Cynthia E. Keen
Breast-conservation surgery becomes an option for pregnant women in their third trimester. For many of these women, radiation therapy can safely be postponed until after birth. But the option of breast-conserving surgery may become available to all pregnant women if electron-beam intraoperative radiation therapy (IORT) is used.
November 16, 2008
Study reports link between breast toxicity and timing of rad therapy
By Cynthia E. Keen
The timing of treatment for breast cancer patients receiving external-beam radiation therapy (EBRT) following intraoperative radiation therapy (IORT) may be an important factor in preventing toxicity. Patients who receive EBRT sooner than five or six weeks after receiving IORT may have a higher risk of developing chronic late toxicity, according to a study by German researchers.
November 16, 2008
GE, UPMC to develop global oncology centers
By AuntMinnie.com staff writers
The University of Pittsburgh Medical Center (UPMC) and GE Healthcare have established a partnership to develop international cancer centers.
November 13, 2008
Physician vacations affect IsoRay revenue in Q1
By AuntMinnie.com staff writers
Medical isotope developer IsoRay posted lower revenues for its first quarter.
November 12, 2008
Nucletron receives Canadian clearance
By AuntMinnie.com staff writers
Radiation oncology firm Nucletron has received Health Canada clearance for its Oncentra Brachy volume-based treatment planning software.
November 12, 2008
Previous Page
Page 319 of 468
Next Page